Atropos Health Partners With Arcadia To Democratize Access To Real World Evidence For Value-based Care Decision Making

By Author: otis
Total Articles: 386
Comment this article

Arcadia has joined the Atropos Evidence™ Network, providing provider customers with access to Atropos Health's evidence applications. This collaboration allows timely, educated clinical decisions based on patient data, enabling comprehensive patient care and value-based performance. The cooperation lets Atropos Health's Life Sciences users use Arcadia's longitudinal study dataset for real-world evidence investigations.

Atropos Health's CEO, Dr. Brigham Hyde, stressed the importance of optimizing clinical decision-making for value-based care, emphasizing the company's data-driven solutions. Arcadia President and CEO Michael Meucci noted that this relationship improves patient outcomes by offering clinical research findings to healthcare companies.

This cooperation follows Atropos Health's Geneva OS™ and ChatRWD™ breakthroughs, which accelerate evidence generation. Creating the Life Sciences Advisory Board, including leaders from top pharmaceutical firms, strengthens Atropos Health's life sciences position.

Atropos Health's Geneva OS-integrated evidence-generation tools enable customers to use Alexandria™, a massive study repository, and the CRAFT Emulation Toolkit™ for enhanced trial design, enrollment, and subgroup analysis. This toolbox generates proof as quickly as Atropos Health's solutions.

Read More - bit.ly/3NVw4Ur